טופמקס ספרינקל 15 מ"ג כמוסות
Country: Israel
Language: Hebrew
Source: Ministry of Health
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
TOPIRAMATE 15 MG
Available from:
J-C HEALTH CARE LTD
ATC code:
N03AX11
Pharmaceutical form:
CAPSULES
Administration route:
PER OS
Manufactured by:
JANSSEN CILAG S.P.A., ITALY
Therapeutic group:
TOPIRAMATE
Therapeutic indications:
In adjunctive therapy of adults and children (from 2 years) with partial seizures and generalized tonic-clonic seizures. In adjunctive therapy of seizures with Lennox-Gastaut syndrome in adults and children. Topamax is indicated as monotherapy in patients with newly diagnosed epilepsy in children aged 7 years and above or for conversion to monotherapy in patients with epilepsy. Topamax is indicated in adults for the prevention of migraines. The use of Topamax in the acute treatment of migraine has not been studied.
Authorization date:
2012-02-01
